C114H102Cl5FN38O7 — CID 158851883
N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-4-fluorobenzamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-methyl-2-oxopiperidine-4-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-methylpyrrolidine-3-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]oxetane-3-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]pyrrolidine-3-carboxamide (PubChem CID 158851883) has the molecular formula C114H102Cl5FN38O7 and a molecular weight of 2312.59 g/mol. Its IUPAC name is N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-4-fluorobenzamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-methyl-2-oxopiperidine-4-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-methylpyrrolidine-3-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]oxetane-3-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]pyrrolidine-3-carboxamide.
| Compound Name | N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-4-fluorobenzamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-methyl-2-oxopiperidine-4-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-methylpyrrolidine-3-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]oxetane-3-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]pyrrolidine-3-carboxamide |
|---|---|
| PubChem CID | 158851883 |
| Molecular Formula | C114H102Cl5FN38O7 |
| Molecular Weight | 2312.59 g/mol |
| Exact Mass | 2308.72 |
| IUPAC Name | N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-4-fluorobenzamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-methyl-2-oxopiperidine-4-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-methylpyrrolidine-3-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]oxetane-3-carboxamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]pyrrolidine-3-carboxamide |
| SMILES | CN1CCC(C(=O)Nc2nc(-c3cc(Cl)c4ncccc4c3)c(-c3ccn(C)n3)nc2N)C1.CN1CCC(C(=O)Nc2nc(-c3cc(Cl)c4ncccc4c3)c(-c3ccn(C)n3)nc2N)CC1=O.Cn1ccc(-c2nc(N)c(NC(=O)C3CCNC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(N)c(NC(=O)C3COC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(N)c(NC(=O)c3ccc(F)cc3)nc2-c2cc(Cl)c3ncccc3c2)n1 |
| InChI | InChI=1S/C24H17ClFN7O.C24H23ClN8O2.C23H23ClN8O.C22H21ClN8O.C21H18ClN7O2/c1-33-10-8-18(32-33)21-20(15-11-14-3-2-9-28-19(14)17(25)12-15)30-23(22(27)29-21)31-24(34)13-4-6-16(26)7-5-13;1-32-8-5-14(12-18(32)34)24(35)30-23-22(26)28-21(17-6-9-33(2)31-17)20(29-23)15-10-13-4-3-7-27-19(13)16(25)11-15;1-31-8-5-14(12-31)23(33)29-22-21(25)27-20(17-6-9-32(2)30-17)19(28-22)15-10-13-4-3-7-26-18(13)16(24)11-15;1-31-8-5-16(30-31)19-18(14-9-12-3-2-6-26-17(12)15(23)10-14)28-21(20(24)27-19)29-22(32)13-4-7-25-11-13;1-29-6-4-15(28-29)18-17(12-7-11-3-2-5-24-16(11)14(22)8-12)26-20(19(23)25-18)27-21(30)13-9-31-10-13/h2-12H,1H3,(H2,27,29)(H,30,31,34);3-4,6-7,9-11,14H,5,8,12H2,1-2H3,(H2,26,28)(H,29,30,35);3-4,6-7,9-11,14H,5,8,12H2,1-2H3,(H2,25,27)(H,28,29,33);2-3,5-6,8-10,13,25H,4,7,11H2,1H3,(H2,24,27)(H,28,29,32);2-8,13H,9-10H2,1H3,(H2,23,25)(H,26,27,30) |
| InChIKey | IZODTPSPCUMEJI-UHFFFAOYSA-N |
| XLogP | 16.86 |
| TPSA | 602.86 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 39 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 165 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2312.59 |
| LogP ≤ 5 | 16.86 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 39 |